REFERENCES

1. An Y, Shen Y, Ma Y, Wang H. Research needs for birth defect prevention and control in China in the genomic screening era. BMJ. 2024;386:e078637.

2. Moustakli E, Christopoulos P, Potiris A, et al. Long-read sequencing and structural variant detection: unlocking the hidden genome in rare genetic disorders. Diagnostics. 2025;15:1803.

3. Fernandes SLE, de Carvalho FAG. Preimplantation genetic testing: a narrative review. Porto Biomed J. 2024;9(4):262.

4. Clinical Appropriateness Guidelines. Genetic testing. Appropriate use criteria: carrier screening in the reproductive setting. GEN05-0925.2. Available from: https://guidelines.carelonmedicalbenefitsmanagement.com/wp-content/uploads/2025/05/Carrier-Screening-in-the-Reproductive-Setting-2025-09-20.pdf?utm [Last accessed on 23 Apr 2026].

5. Kirovakov Z, Gyokova EH, Hinkova NH, Konova EI. Recurrent pregnancy loss: etiology, pathophysiology, diagnosis and treatment. J Biomed Clin Res. 2025;18:1-10.

6. Han C, Zhang Y, Xue J, Liu Y, An Y, Li H. Pregnancy outcomes and short-term follow-up of fetuses with recurrent microdeletion-microduplication syndromes featuring variable penetrance in prenatal diagnosis. J Transl Genet Genom. 2025;9:114-29.